Healthcare Equipment and Supplies
Company Overview of Amaranth Medical, Inc.
Amaranth Medical, Inc. is a holding company operating through its subsidiary Amaranth Medical Pte Ltd. that develops biodegradable stents to treat peripheral vascular disease (PVD). The company was incorporated in 2006 and is based in Mountain View, California with an additional office in Singapore.
1145 Terra Bella Avenue
Mountain View, CA 94043
Founded in 2006
Key Executives for Amaranth Medical, Inc.
Founder and Chief Scientific Officer
Compensation as of Fiscal Year 2014.
Amaranth Medical, Inc. Key Developments
Amaranth Medical Reports Positive Safety and Feasibility Findings for the FORTITUDE(TM) Bioresorbable Scaffold
Oct 28 13
Amaranth Medical presented positive six-month angiographic results from its first-in-human study including patients undergoing percutaneous coronary intervention (PCI) with single coronary lesions. The FORTITUDE(TM) non-drug eluting bioresorbable scaffold was successfully delivered in 12 patients within the target lesion. Post-deployment angiographic and IVUS analysis indicated that the FORTITUDE scaffold maintained its mechanical integrity, showing no indication of vessel recoil or other structural failures. At the time of the presentation, 10 patients had completed six-month angiographic follow up and six patients had available independent angiographic analysis indicating 0% binary restenosis. The data was presented at the "Next generation DES and bioabsorbable scaffolds" session at the Transcatheter Cardiovascular Therapeutics (TCT) meeting on October 27, 2013 in San Francisco, CA. Six-month angiographic follow-up data is available on 10 of the 13 patients enrolled in the first cohort and demonstrate excellent biomechanics and biocompatibility of the scaffolds. An independent core laboratory has reviewed findings on the first six patients, and affirmed that late lumen loss is similar to that observed with bare metal stents. Intravascular ultrasound and optical coherent tomography (OCT) images indicate that the scaffolds are fully opposed to the vessel walls with no indication of recoil or other compromise to their mechanical integrity.
Similar Private Companies By Industry
Recent Private Companies Transactions
January 14, 2014
Most Searched Private Companies
Sponsored Financial Commentaries